Successful treatment of Heyan Kuntai capsule combined with hormonal therapy in an adolescent with diminished ovarian reserve: a case report

一例卵巢储备功能减退的青少年患者成功接受和颜昆泰胶囊联合激素治疗的病例报告

阅读:4

Abstract

BACKGROUND: Diminished ovarian reserve (DOR), a common female disease, results in reduced fertility and menstrual disorders. Patients without timely treatment often suffer from infertility, ovarian insufficiency, premature ovarian failure and early onset or worsened perimenopausal symptoms caused by estrogen fluctuation or deficiency. However, there is a lack of effective methods to improve ovarian reserve function. CASE PRESENTATION: Here, we report a case of a 13-year-old female with 2-year menstrual disorder. The anti-mullerian hormone (AMH) levels were test twice, with interval of 2 months, yielding results of 0.41 ng/mL and 0.50 ng/mL, respectively. Colour Doppler ultrasound examination showed that there were 4-6 antral follicles bilaterally. The patient was diagnosed with DOR. She was treated with Heyan Kuntai capsule (HYKT) combined with hormonal therapy (HT). Post treament, her AMH level, follicle stimulating hormone level and AFC normalized. Discontinuation of HYKT and continuation of HT alone for 5 months proved ineffective. Consequently, HYKT in combination with HT was continued, leading to normal ovarian reserve function restoration. No adverse reactions were observed during the 4-year follow-up. CONCLUSIONS: This case highlights the importance of including DOR as a diagnostic consideration in adolescents with menstrual disorders during clinical evaluation. AND combining HYKT with HT might contribute to potential improvements in ovarian function in DOR patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。